Susvimo is also approved to treat diabetic macular edema and age-related macular degeneration, and the medication, ranibizumab, is delivered through an ocular implant that is refilled every nine ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved Susvimo® (ranibizumab injection) 100 mg/mL for the ...

Susvimo is now available to U.S. retina specialists and their patients with DR ... the most common ocular side effects included conjunctival hemorrhage, eye pain, vitreous floaters, and increased ...

Susvimo is the first and only FDA-approved, continuous delivery treatment shown to maintain vision in people with DR with ...

Ayres shares insights on using a trocar-free, 27-gauge vitrector to improve surgeon comfort and patient safety in anterior ...

Bausch + Lomb launched a preservative-free form of Lumify redness-reducing eye drops in the U.S., according to a press release. A few years ago at the ASCRS meeting, I had the chance to present in ...

A retinal detachment, where the retina peels away from the back of the eye is an eye emergency and needs treatment straight away. A sudden increase in floaters (moving lines and dots in your vision), ...

Abstract: It is well known that retinal diseases are sometimes identified by tortuosity of the vessels, presence of exudates and hemorrhages while lesions of tissues are associated to diabetic ...

Retina/Vitreous Technology Trauma Meeting News Podcasts ... Hawaiian Eye and Retina 2026 View View meeting calendar Podcasts View more Ophthalmology May 20, 2025 61 min listen ...